Edition:
United States

Sangamo Therapeutics Inc (SGMO.OQ)

SGMO.OQ on NASDAQ Stock Exchange Global Select Market

4.00USD
24 Feb 2017
Change (% chg)

$0.15 (+3.90%)
Prev Close
$3.85
Open
$3.75
Day's High
$4.05
Day's Low
$3.75
Volume
88,742
Avg. Vol
164,799
52-wk High
$7.59
52-wk Low
$2.65

SGMO.OQ

Chart for SGMO.OQ

About

Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is focused on translating science into genomic therapies that transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The Company has developed technologies available for gene-based... (more)

Overall

Beta: 2.99
Market Cap(Mil.): $282.50
Shares Outstanding(Mil.): 70.62
Dividend: --
Yield (%): --

Financials

  SGMO.OQ Industry Sector
P/E (TTM): -- 44.08 29.63
EPS (TTM): -1.08 -- --
ROI: -42.07 -3.35 12.96
ROE: -43.78 5.80 14.11

More From Around the Web

Competitors

  Price Chg
Novo Nordisk A/S (NOVOb.CO) kr.249.30 +0.50
Pfizer Inc. (PFE.N) $34.26 +0.20
Novartis AG (NOVN.S) CHF77.60 0.00
Merck & Co., Inc. (MRK.N) $66.16 +0.31
Roche Holding Ltd. (ROG.S) CHF245.20 +0.10
Roche Holding Ltd. (RO.S) CHF248.50 +0.30
Bayer AG (BAYGn.DE) €104.25 -0.85
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €80.58 +0.45
GlaxoSmithKline plc (GSK.L) 1,639.50 +7.00

Earnings vs. Estimates